The effect of Chlorella Volgaris versus Arthichoke on patients with NAFLD- A randomized clinical trial
Phase 2
- Conditions
- Fatty liver.nonalcoholic steatohepatitis
- Registration Number
- IRCT2014101619554N1
- Lead Sponsor
- Vice Chancellor for Research,Zanjan University of Medical Sciences
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete
- Sex
- All
- Target Recruitment
- 200
Inclusion Criteria
Proven fatty liver by Ultrasound, Increase liver enzyme alanine aminotransferase (ALT) between 1.5 to 5 times the normal; The mean BMI between 25-35
Exclusion criteria:
Patients with nonalcoholic steatohepatitis; Patients with systemic diseases such as diabetes - and other inflammatory diseases; Positive serology for hepatitis viral, anti-mitochondrial antibody (AMA); positive anti- nuclear antibody (ANA); TIBC increased serum iron and transferrin,TIBC, positive serum ceruloplasmin; Other secondary causes of fatty liver, Transferrin saturation more than 45.
Exclusion Criteria
Not provided
Study & Design
- Study Type
- interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method iver Function Test. Timepoint: 2m after intervention. Method of measurement: Eliza method.
- Secondary Outcome Measures
Name Time Method BMI(Body Mass Index). Timepoint: 2m. Method of measurement: kg/m2.;Blood Presser. Timepoint: 2m. Method of measurement: Digital manometer.;Lipid Profil. Timepoint: 2month. Method of measurement: Eliza.;Blood sugar. Timepoint: 2month. Method of measurement: Eliza.